syha1805
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2020 (NCT04645901)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04977570 | Phase 1 | Jul 31, 2021 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., Shijiazhuang Pharma Group (CSPC) |
| NCT04645901 | Phase 1 | Dec 31, 2020 | Shijiazhuang Pharma Group (CSPC) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shijiazhuang Pharma Group (CSPC) | For profit | 2 | 2 | 1 | 2020 |
| CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | For profit | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1